![Eduardo Bruno Martins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eduardo Bruno Martins
Plus aucun poste en cours
Fortune : 240 650 $ au 31/05/2026
Profil
Eduardo Bruno Martins is the founder of Martins Bruno Consulting LLC, founded in 2017.
Former jobs include Vice President-Medical Affairs & Medical Director at SciClone Pharmaceuticals LLC from 1997 to 2005; Senior Director-Medical Affairs for Hepatitis at Gilead Sciences, Inc. from 2010 to 2015; Vice President-Clinical Development at Allergan, Inc. from 2018 to 2020; Vice President-Medical Affairs at InterMune, Inc.; Vice President-Clinical Development at Dynavax Technologies Corp.; Professor at Federal University of Rio de Janeiro from 1995 to 1999; Chief Medical Officer at Sagimet Biosciences, Inc. from 2021 to 2026; SVP-Liver & Infectious Diseases Drug Development at Eiger BioPharmaceuticals, Inc. from 2015 to 2017; Vice President-Clinical Development at AbbVie, Inc. in 2020.
Education includes a doctorate from the University of Oxford conferred in 1995 and a doctorate from Federal University of Rio de Janeiro conferred in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 33 011 ( 0,05 % ) | 240 650 $ | 31/05/2026 |
Anciens postes connus de Eduardo Bruno Martins
| Sociétés | Poste | Fin |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Directeur Technique/Scientifique/R&D | 20/04/2026 |
| ABBVIE INC. | Corporate Officer/Principal | 01/12/2020 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/05/2020 |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 01/08/2017 |
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/10/2015 |
Formation de Eduardo Bruno Martins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Federal University of Rio de Janeiro
 Federal University of Rio de Janeiro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Martins Bruno Consulting LLC |
